Elevance Health stock rises 1.10 percent ahead of Q3 results
Published on 10/07/2026 at 16:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elevance Health stock had a market capitalization of USD 87.7 billion on October 7, 2026, while its NYSE quote was up 1.10 percent during trading. The move came as the insurer approached its scheduled third-quarter results date and investors weighed the latest earnings and analyst estimates.
Stock stays below yearly high
Elevance Health was trading at USD 404.49 at 10:56 a.m. ET on October 7, 2026, compared with a session open of USD 401.00. The price was 7.28 percent below the 52-week high of USD 436.24 and remained above the 52-week low of USD 274.84.
The current quote leaves the stock near the upper half of its yearly range, but the daily gain alone does not remove the valuation question ahead of the next report. Trading volume stood at 84,054 shares at the same timestamp, giving the move a measured intraday profile.
Quarterly earnings set the benchmark
According to MarketBeat on October 6, 2026, Elevance reported adjusted earnings per share of USD 7.45 for its latest quarter, above the USD 6.21 consensus estimate. Revenue reached USD 49.83 billion against a USD 48.88 billion estimate, while the previous-year quarter had produced EPS of USD 8.84.
The comparison is important because the earnings beat came alongside lower year-over-year EPS, even as quarterly revenue increased 0.8 percent. For investors, the October report will show whether medical-cost trends and government-program performance can support the company valuation.
Analysts see further upside
MarketBeat said the consensus rating was Moderate Buy, based on 23 analysts, including 15 Buy ratings and eight Holds. The average 12-month price target was USD 440.90, which lies 9.00 percent above the October 7 price.
The range of recent published targets extended from USD 393.00 to USD 488.00, showing a wide gap between cautious and optimistic assumptions. That spread places greater emphasis on the next guidance update than on the label of the overall consensus.
Results date sets next checkpoint
According to Business Wire on October 5, 2026, Elevance will release third-quarter 2026 results on October 21, 2026, at 6:00 a.m. ET and discuss the outlook during a conference call at 8:30 a.m. ET.
That report will provide the next direct test of the company's earnings trajectory. The combination of a USD 404.49 intraday price, a USD 440.90 consensus target and the prior quarter's USD 7.45 adjusted EPS defines the key setup for the stock.
NYSE quote and market value
Elevance Health was last at USD 404.49 on the NYSE at 10:56 a.m. ET on October 7, 2026. The stock was up 1.10 percent on the session, with a 52-week range of USD 274.84 to USD 436.24.
Elevance Health stock details
- Company: Elevance Health, Inc.
- ISIN: US0367521038
- Ticker: ELV
- Trading venue: NYSE
- Price (as of October 7, 2026, 10:56 a.m. ET): USD 404.49
- Market capitalization: USD 87.7 billion (as of October 7, 2026)
- 52-week range: USD 274.84-436.24
- Sector / Industry: Health Care / Managed Health Care
Upcoming dates for Elevance Health stock
- October 21, 2026: Third-quarter 2026 results and conference call
